ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

DCT Board to Study Modifications Of Existing Cooperative Group System

June 13, 1986

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

April 22, 2005

GYN Group: Open Surgery Would Cost More Lives Than Morcellation

July 25, 2014

DRCCA Board Okays Chemoprevention RFA, Referral Guidelines

January 29, 1982

In Brief: Congresswomen Receive FASEB Awards for Public Service for Support of NIH

May 2, 1997